Scott Eggener retweeted
🚨 New in @JUrology: "Language as a powerful influencer in #ProstateCancer" 🚨
✒️ New essay w/ @uroegg & Jessica Rett @LinguisticsUcla
📄 Words are neither neutral nor fixed
♋️We use prostate cancer, a disease spanning indolent to lethal under one name, as a case study:
👉 MRI "lesion"
👉 clinically "significant" disease
👉 "positive" margin
❓ We all know these terms shape how patients hear us
🧵 5 strategies you can use today 👇
Scott Eggener retweeted
Scott, you know where I stand on this. Molecular features don’t matter when clinical characteristics are BENIGN. Let’s be pragmatic. Patients don’t understand. I think this would be a great topic for the plenary at the AUA annual meeting. 😉 @AmerUrological
Scott Eggener retweeted
The @UCLAHealth Urology Spring 2026 newsletter is out. Take a look at program highlights, alumni profiles, and update from the chair.
uclahealth.org/sites/default…
Scott Eggener retweeted
Prof Hugosson: Göteborg trial with 30 year outcomes! NND falls to -6-, with greatest benefit for men 50-59 at randomization. Despite no image guidance, high overdx, and suboptimal tx. Best evidence we have re: the evidence for #prostatecancer screening. Get tested! #eau26 @uroweb
Scott Eggener retweeted
Happy #matchday soon to be Urologists
Congrats to soon-to-be-doctors Bettencourt, Lerman, Borrell, and Yoffe
We look forward to welcoming you to the @UCLAHealth Urology family this summer.
For those who didn't receive the news they hoped for, your journey is still beginning.
Scott Eggener retweeted
Our annual state of the art is just around the corner.
Whether you are an alumni, colleague practicing nearby, or traveling for your CME we hope you join us for this immersive course.
There is content for all. Info and registration below
web.cvent.com/event/159d0f39…
Scott Eggener retweeted
Thanks again #GUCast @declangmurphy @RenuEapen for hosting @uroegg and me to riff a bit more re: nomenclature for GG1 #prostatecancer! Always great to catch up.
m.youtube.com/watch?v=BDtE4i…
Scott Eggener retweeted
You have to hear this "brilliant" idea from @CanesDavid who formed @WellPrept to "personalize" educating patients while reducing #burnout for physicians.
Sounds too good to be true? hear this entrepreneur on this #HealthcareUnfiltered episode. @uroegg will listen.
Full video.
Scott Eggener retweeted
Argument for keeping pattern 3 as prostate cancer: "Because we can't be sure that we haven't missed pattern 4 in the biopsy". Same can now be said of ASAP. Therefore either ASAP is cancer or pattern 3 isn't.
Really like this little paper we've published in the brilliant new @BJUICompass on 10 yrs of #ASAP at #Oxford_Urology.
THM - not all subsequent biopsies after ASAP are #LowGrade. In fact 24.1% had GG≥2 within 2yrs of diagnosis of ASAP.
@thineskrishna
doi.org/10.1002/bco2.407
Scott Eggener retweeted
"Here we provide a comprehensive overview of the characteristics of GG1 prostatic adenocarcinoma ... all supporting the movement to reclassify GG1 disease as a non-cancerous entity." @urogeek @uroegg bjui-journals.onlinelibrary.…
Scott Eggener retweeted
Top 10 #HealthcareUnfiltered most watched videos in 2023, and it was a surprise.
Number ONE: The epic debate on #ProstateCancer BTW @uroegg of @UCCancerCenter & Dr. Epstein of @HopkinsMedicine where they argue if we should call Gleason 6 disease a "cancer."
Full video here.
Scott Eggener retweeted
University of Chicago employee Bentley Wall was seen removing posters of Israeli children kidnapped by Hamas terrorists.
When asked why he was removing them, he answered “I don’t care” and called police.
Scott Eggener retweeted
Exciting times for Hyde Park @uroegg @Agarwal_CaB
The Illinois Health Facilities and Services Review Board approved the University of Chicago Medicine’s plans to build an $815 million, 575,000-square-foot building dedicated to cancer research and care on its medical campus on the city’s South Side. ms.spr.ly/6012gtR62
Scott Eggener retweeted
Great timing re: yesterday's #aua23 GG1 debate: @Saouduro @uroegg et al paper out today in @EurUrolFocus documenting demographic drivers of opinions re: GG1 prostate cancer. reader.elsevier.com/reader/s…
Scott Eggener retweeted
🔝 Check out the top-mentioned #JCO article of 2022 ‼️
Low-Grade #ProstateCancer: Time to Stop Calling It Cancer: fal.cn/3uI1M #PCSM #pancsm @uroegg @dr_coops
Scott Eggener retweeted

Alireza Ghoreifi, MD@alirezaghoreifi24 Nov 2022
United States
United StatesConnected via United States App StoreAccount-level information, not a live location or per-post device.
➡️Largest series of Rob PC-RPLND: 90 pts, 7 centers.
🎯#Robotic PC-RPLND is safe with effective short-term #cancer control in well-selected pts at centers with expertise in #testicularcancer and MIS.
@Hoomandjaladat @USC_Urology @UroOnc
🔗authors.elsevier.com/c/1g8V1…
Scott Eggener retweeted
Articles in Press: Removing the Designation of Cancer from Grade Group 1 Disease Will Do More Good than Harm
buff.ly/3AFf3HC
@VickersBiostats @dr_coops @uroegg
#urology #SoMe
Scott Eggener retweeted
New Platinum Priority Editorial from @VickersBiostats @dr_coops @uroegg
Removing the Designation of Cancer from Grade Group 1 Disease Will Do More Good than Harm
buff.ly/3sjtbld



































